Product information
From Health Canada
Current status:
Cancelled Post Market
Current status date:
1997-10-16
Original market date: See footnote 1
1995-12-31
Product name:
TRIAMINIC DECONGEST+EXPECT LIQUI-GELS CAP
DIN:
02172437 Electronic product monograph is not available
Company:
SANDOZ CANADA INC
385 Bouchard Blvd
Dorval
Quebec
Canada
H9S 1A9
Class:
Human
Dosage form(s):
Capsule
Route(s) of administration:
Oral
Number of active ingredient(s):
2
Schedule(s):
OTC
American Hospital Formulary Service (AHFS): See footnote 3
48:16.00
Anatomical Therapeutic Chemical (ATC): See footnote 4
R05CA10 COMBINATIONS
Active ingredient group (AIG) number:See footnote5
0203205002
Active ingredient(s) | Strength |
---|---|
GUAIFENESIN | 100 MG / CAP |
PSEUDOEPHEDRINE HYDROCHLORIDE | 30 MG / CAP |